Navigation Links
A new ally in the battle against cocaine addiction
Date:1/2/2010

A recent study shows that a bacterial protein may help cocaine addicts break the habit.

Cocaine esterase (CocE) is a naturally-occurring bacterial enzyme that breaks down cocaine, thereby reducing its addictive properties. The efficacy of CocE in animals and its suitability for treatment of addiction has been limited by its short half-life in the body.

A recent study, published in the Journal of Pharmacology and Experimental Therapeutics and reviewed by Faculty of 1000 Medicine's Friedbert Weiss, demonstrates that a more stable version of CocE, double mutant or DM CocE, significantly decreased the desire for cocaine and prevented death from cocaine overdose.

In the study, rats were trained to self-administer cocaine by pressing a button in their cage, mimicking the need for regular doses of the drug during addiction. Rats treated with the double mutant form of CocE pressed the button to receive cocaine less often, suggesting that DM-CocE broke down the drug and dampened addiction.

DM-CocE decreased the rats' urge for cocaine but not for an addictive analogue, highlighting the degree of specificity for cocaine. Weiss notes that the DM-CocE enzyme also provides "long-lasting protection" against the toxic effects of a potentially lethal dose.

Though the effects of CocE can be overcome by a sufficiently large dose of cocaine, the present findings suggest that CocE has great promise as a drug abuse treatment.

Weiss says, "These therapeutic approaches may therefore not be "fail-safe" for reducing cocaine intake by determined users" but "long-acting forms of CocE represent potentially valuable treatment approaches not only for the prevention of cocaine-induced toxicity but also for ongoing cocaine abuse in humans."


'/>"/>

Contact: Steve Pogonowski
press@f1000.com
Faculty of 1000: Biology and Medicine
Source:Eurekalert

Page: 1

Related biology news :

1. Stem cells battle for space
2. Nanoparticle-based battlefield pain treatment moves a step closer
3. Battle of the sexes benefits offspring, says research
4. The battle for CRTC2: How obesity increases the risk for diabetes
5. Queens scientists find new way to battle MRSA
6. Carbon sinks losing the battle with rising emissions
7. Researchers identify potential new weapon in battle against HIV infection
8. Color My Pyramid nutrition education program battles obesity in DC schools
9. In Vietnam, alongside progress, a battle for life
10. LSU and Ohio State battle on football field, collaborate in research field
11. In promiscuous antelopes, the battle of the sexes gets flipped
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/22/2016)... December 22, 2016 SuperCom (NASDAQ: ... solutions for the e-Government, Public Safety, HealthCare, and Finance sectors announced ... has been selected to implement and deploy a community-based supportive services ... Northern California , further expanding its presence in the state. ... This new program, ...
(Date:12/20/2016)... N.C. and GENEVA, Dec, 20, 2016 /PRNewswire/ ... biometric data sensor technology, and STMicroelectronics ... the spectrum of electronics applications, announced today the ... development kit for biometric wearables that includes ST,s ... with Valencell,s Benchmark™ biometric sensor system. ...
(Date:12/16/2016)... MIAMI , Dec. 16, 2016   ... intuitive Identity management products and solutions and a ... announced today that it is offering seamless, integrated ... Edam security entrance products. The solutions provide IdentyTech,s ... to secure their facilities from crime and theft. ...
Breaking Biology News(10 mins):
(Date:1/11/2017)... ... January 11, 2017 , ... Back pain relief technology is now available without ... for positive back pain relief for WAR members. , This spinal restoration platform boasts ... life changing for millions suffering from chronic back pain. , What A Relief ...
(Date:1/11/2017)... and BENGALURU, India , Jan. ... Biocon Ltd. (BSE code: 532523, NSE: BIOCON) today announced ... accepted Mylan,s biologics license application (BLA) for MYL-1401O, a ... This product is a proposed biosimilar to branded trastuzumab, ... The anticipated FDA goal date set under the Biosimilar ...
(Date:1/11/2017)... GAITHERSBURG, Md. , Jan. 11, 2017 /PRNewswire/ ... clinical-stage gene delivery company, announced today that its ... will present a talk entitled  "AdenoVerse™ platform for ... during the Biotech Showcase at the upcoming Phacilitate ... Miami , Florida.  Dr. Brough,s ...
(Date:1/11/2017)... (PRWEB) , ... January 11, 2017 , ... ... signed a multi-year license agreement with Poseida Therapeutics Inc, the San Diego based ... genetic data. Poseida Therapeutics selected KBioBox in order to harness KBioBox’s powerful BioEngine ...
Breaking Biology Technology: